Thermaquil
Thermaquil is a Philadelphia-based medical-device company developing drug-free, reversible nerve block devices that manage severe pain and treat overactive-nerve conditions without drugs or electrical stimulation, selling to healthcare providers and patients via direct, quote-based custom device orders.
- Company typePrivate
- Founded2017
- HeadquartersPhiladelphia, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Thermaquil does
Thermaquil is a Philadelphia-based, privately held medical-device company founded in 2017 that develops drug-free nerve block devices intended to manage severe pain and treat conditions caused by overactive nerves without pharmaceutical intervention or electrical stimulation. The company describes its product as a reversible nerve block device built on a proprietary method architecture, and it offers both a standard device and custom-engineered units for specific pain management and therapeutic applications.
The company serves two primary customer groups: healthcare providers and medical institutions seeking non-pharmaceutical pain management options, and patients suffering from chronic or nerve-related pain who want drug-free alternatives. Its revenue mechanics are hardware-based, relying on direct sales of devices (and custom devices) to enterprise healthcare buyers under a quote-based pricing model. Distribution is direct, with no disclosed channel partners, and the company states it is expanding its network of patients, providers, partners, and investors.
Thermaquil is at an early stage of commercialization. It has received two non-dilutive grants from the National Science Foundation ($225,000 in June 2019 and $1,000,000 in September 2020) and remains a sub-ten-person team. Operating-status signals point to active R&D and stakeholder outreach, but no regulatory clearances, named customers, pricing, revenue, partnerships, patents, or leadership details are disclosed in the available data.
Thermaquil firmographics
Firmographics- Name
- Thermaquil
- Website
- https://thermaquil.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Thermaquil is a Philadelphia-based medical-device company developing drug-free, reversible nerve block devices that manage severe pain and treat overactive-nerve conditions without drugs or electrical stimulation, selling to healthcare providers and patients via direct, quote-based custom device orders.
- Ownership category
- akta.pro rank
Thermaquil industry classification
Industry- Product category
- Pain Management Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM)
Keywords
Where Thermaquil is headquartered
LocationHeadquarters
- HQ city
- Philadelphia
- HQ country
- United States
- HQ region
- North America
Markets served
Thermaquil business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Revenue generated from the sale of drug-free nerve block devices, with potential for custom device manufacturing to address specific pain and nerve condition needs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Custom Device Quote-based Pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Thermaquil product offering
Product offeringCore offering
Thermaquil develops and sells drug-free nerve block devices that manage severe pain and treat conditions caused by overactive nerves without the use of pharmaceutical drugs or electric stimulation. The company also offers custom-engineered devices tailored to specific pain management and therapeutic applications, targeting healthcare providers and patients seeking non-pharmaceutical alternatives to traditional nerve pain treatment.
Product overview
Thermaquil offers drug-free nerve block devices as its core product line. The company provides both standard nerve block devices for pain management and custom devices tailored to block pain and treat other conditions caused by overactive nerves. The product portfolio centers on non-pharmaceutical approaches to nerve-related pain and medical conditions.
Differentiator
Problem solved
Functional benefit
Products and services
- Thermaquil Nerve Block Device
Companies that use Thermaquil
Customer profileSegments2 records
Ideal customer profiles2 records
Thermaquil technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Thermaquil partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights4 records
Thermaquil competitors and assessment
Company assessmentEmerging players
- Axonics Modulation Technologies: Focused neuromodulation company with sacral and recently expanded peripheral nerve stimulation indications. Comparable as a smaller, device-only neuromodulation company whose growth trajectory illustrates both the upside and the execution bar facing Thermaquil.
Broad incumbents
- Medtronic: Global medtech leader with spinal cord stimulation (Intellis) and peripheral nerve stimulation (Vanta) portfolios targeting chronic and neuropathic pain. Comparable as the dominant incumbent in nerve-targeted pain devices, against which Thermaquil's drug-free, non-electrical approach must position.
- Avanos Medical: Sells non-opioid pain management solutions including the ON-Q and ambIT pain pumps and Coolief cooled radiofrequency for interventional pain. Comparable as a broader non-opioid pain device vendor competing for the same hospital and pain clinic call points.
- Boston Scientific: Offers Precision Montage and Spectra spinal cord stimulation systems and the WaveWriter Alpha spinal cord stimulator, serving the same interventional pain management call point as Thermaquil. Comparable as a large incumbent pursuing both SCS and PNS indications.
- Abbott: Markets Proclaim and Eterna spinal cord stimulation systems, plus the Prodigy MRI system, and has invested heavily in dorsal root ganglion (DRG) stimulation for neuropathic pain. Directly comparable as a diversified neuromodulation incumbent shaping reimbursement and clinical evidence in pain nerve block.
Direct peers
- Nevro: Pure-play spinal cord stimulation company (Senza, HFX) with 10 kHz therapy positioned for chronic and neuropathic pain. Closest direct peer because it is a device-only pain nerve-block company whose commercial trajectory and clinical evidence benchmarks Thermaquil must eventually exceed.
- Stimwave Technologies: Developed wireless, micro-implant peripheral nerve stimulation systems for chronic pain. Comparable as a small neuromodulation device company with a differentiated hardware approach and an emphasis on drug-free, nerve-targeted pain relief.
- SPR Therapeutics: Developer of the Sprint peripheral nerve stimulation system, a minimally invasive, temporary PNS platform for acute and chronic pain. Comparable as a focused nerve-block device company at a similar size and stage, pursuing non-opioid pain management via direct nerve targeting.
- Nalu Medical: Maker of a miniaturized, battery-free peripheral nerve stimulation implant for chronic pain. Comparable as a small, device-only pain nerve-block company differentiating on form factor and patient experience, similar in scale and stage to Thermaquil.
- electroCore: Markets non-invasive vagus nerve stimulation (gammaCore) for migraine and cluster headache, and has explored other nerve stimulation indications. Comparable as a drug-free, nerve-targeted device company, although it uses electrical stimulation where Thermaquil does not.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat1 record
Key risks6 records
Key highlights4 records
Customer concentration
Thermaquil social profiles
Digital presenceThermaquil financial estimates
Financial estimateRevenue estimate
Valuation estimate
Thermaquil leadership team
Management profileNumber of profiles
Thermaquil funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Thermaquil M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Thermaquil
What does Thermaquil do?
Thermaquil develops and sells drug-free nerve block devices that manage severe pain and treat conditions caused by overactive nerves without the use of pharmaceutical drugs or electric stimulation. The company also offers custom-engineered devices tailored to specific pain management and therapeutic applications, targeting healthcare providers and patients seeking non-pharmaceutical alternatives to traditional nerve pain treatment.
Is Thermaquil a public or private company?
Thermaquil is a private company. It is classified as unknown and is currently operating.
When was Thermaquil founded?
Thermaquil was founded in 2017. It employs 1 to 10 people.
Where is Thermaquil based?
Thermaquil is headquartered in Philadelphia, United States, in the North America region.
How does Thermaquil make money?
One revenue line is on record: medical Device Sales.
Who are Thermaquil's main competitors?
Axonics Modulation Technologies is listed as an emerging player. Broad incumbents are Medtronic, Avanos Medical, Boston Scientific and Abbott. Direct peers are Nevro, Stimwave Technologies, SPR Therapeutics, Nalu Medical and electroCore.
Does Thermaquil have an API?
No public API is recorded for Thermaquil.
What industry is Thermaquil in?
Thermaquil's product category is Pain Management Medical Devices. Its primary akta.pro industry code is HLAKAIAM, Pain Medicine (Interventional/Neuropathic Pain). Its NAICS code is 334510 and its SIC code is 3845.